A detailed history of Aviance Capital Partners, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Aviance Capital Partners, LLC holds 5,721 shares of BAX stock, worth $189,994. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,721
Holding current value
$189,994
% of portfolio
0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$32.85 - $40.26 $187,934 - $230,327
5,721 New
5,721 $217,000
Q1 2024

Apr 17, 2024

BUY
$37.88 - $43.77 $211,484 - $244,367
5,583 New
5,583 $238,000
Q2 2023

Aug 04, 2023

BUY
$39.98 - $47.68 $359 - $429
9 Added 0.16%
5,686 $259,000
Q1 2023

May 10, 2023

BUY
$37.58 - $52.57 $225 - $315
6 Added 0.11%
5,677 $230,000
Q4 2022

Feb 06, 2023

BUY
$49.7 - $57.71 $347 - $403
7 Added 0.12%
5,671 $289,000
Q3 2022

Nov 09, 2022

BUY
$53.86 - $66.8 $269 - $334
5 Added 0.09%
5,664 $305,000
Q2 2022

Aug 08, 2022

BUY
$63.83 - $80.0 $71,681 - $89,840
1,123 Added 24.76%
5,659 $363,000
Q2 2021

Aug 06, 2021

BUY
$80.5 - $88.01 $94,829 - $103,675
1,178 Added 35.08%
4,536 $365,000
Q1 2020

May 05, 2020

SELL
$71.57 - $93.3 $21,470 - $27,990
-300 Reduced 8.2%
3,358 $273,000
Q1 2019

May 01, 2019

BUY
$64.48 - $81.31 $64 - $81
1 Added 0.03%
3,658 $297,000
Q4 2018

Feb 11, 2019

SELL
$61.45 - $77.8 $61 - $77
-1 Reduced 0.03%
3,657 $240,000
Q3 2018

Nov 09, 2018

BUY
$70.71 - $77.75 $70 - $77
1 Added 0.03%
3,658 $282,000
Q1 2018

May 03, 2018

SELL
$62.56 - $72.26 $62 - $72
-1 Reduced 0.03%
3,657 $237,000
Q3 2017

Nov 09, 2017

BUY
$59.5 - $64.61 $217,651 - $236,343
3,658
3,658 $230,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Aviance Capital Partners, LLC Portfolio

Follow Aviance Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.